Hardcover: 214 pages
Publisher: Routledge; New edition edition (July 28, 2011)
Language: English
ISBN-10: 1409430316
ISBN-13: 978-1409430315
Product Dimensions: 1 x 7 x 10 inches
Shipping Weight: 1.4 pounds
Average Customer Review: 4.5 out of 5 stars See all reviews (2 customer reviews)
Best Sellers Rank: #1,795,795 in Books (See Top 100 in Books) #116 in Books > Business & Money > Industries > Pharmaceutical & Biotechnology #209 in Books > Business & Money > Management & Leadership > Distribution & Warehouse Management #1769 in Books > Textbooks > Business & Finance > Business Development
With this book Brian Smith demonstrates the audacity to predict the future of the pharmaceutical industry. He first provides an historical overview of the path that has lead the pharmaceutical industry to evolve from the classic apothecary form, to what it is today. Now, the industry is faced with many challenges, such as increasing health care costs while resources devoted to health care decrease. Many factors are described that herald the end of the traditional pharma business model. And why blockbuster thinking is no longer effective in today's environment.He then identifies several new business models, adapted to the new environment, and demonstrates the innovative thinking needed to create them. Also, the author submits many quotes from leaders of pharmaceutical companies who are currently responsible for innovation to survive the massive changes presented in the healthcare environment today. Not afraid of Darwinian thought, the underlying thinking seems strongly influenced of the premise that those who can adapt to new conditions shall survive.In essence, the book takes a scholarly approach on how the future of the pharmaceutical industry may be architected. It takes many factors, including social, environmental, and technical factors from our current environment into account, to arrive at its models for the realistic near future. Even more, the book gives tangible, ready-to-use strategies to adapt to the requirements for each individual business model.The book may be valuable for those involved in pharmaceuticals, medicine, medical industry, as well as those in business, or others keen to link to or to understand the evolution eminent in pharmaceutical companies and overall, to adopt evolutionary adaptive tactics.
Must read! And very easy to read, with many insights and illustrations from interviews of senior leaders of the industry or its ecosystem
The Future of Pharma: Evolutionary Threats and Opportunities Bad Language, Naked Ladies, and Other Threats to the Nation: A Political History of Comic Books in Mexico The Rainforests of West Africa: Ecology, Threats, and Protection Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare Healthcare Investing: Profiting from the New World of Pharma, Biotech, and Health Care Services (McGraw-Hill Finance & Investing) Crisis Leadership Now: A Real-World Guide to Preparing for Threats, Disaster, Sabotage, and Scandal Entry Threats and Pricing in the Generic Drug Industry ADHD Nation: Children, Doctors, Big Pharma, and the Making of an American Epidemic Improving Web Application Security: Threats and Countermeasures Show Me the Money, Honey: The Truth about Big Pharma's War on Salt, Chocolate, Cholesterol & the Natural Health Products That Could Save Your Life The Antidote: Inside the World of New Pharma A Nation of Takers: America's Entitlement Epidemic (New threats to freedom series) The Mystery of the Shemitah: The 3,000-Year-Old Mystery That Holds the Secret of America's Future, the World's Future, and Your Future! The Mystery of Shemitah: The 3,000-Year-Old Mystery That Holds the Secret of America's Future, the World's Future, and Your Future The Mystery of the Shemitah With DVD: The 3,000-Year-Old Mystery That Holds the Secret of America's Future, the World's Future, and Your Future! The Secrets of Economic Indicators: Hidden Clues to Future Economic Trends and Investment Opportunities (3rd Edition) The Design of Innovation: Lessons from and for Competent Genetic Algorithms (Genetic Algorithms and Evolutionary Computation) Globalization, Economic Development and Inequality: An Alternative Perspective (New Horizons in Institutional and Evolutionary Economics Series) Soft Computing: Integrating Evolutionary, Neural, and Fuzzy Systems